
北美临床试验成像市场预测至 2028 年 - COVID-19 影响和区域分析 - 按模态 [断层扫描、磁共振成像 (MRI)、超声波、正电子发射断层扫描 (PET)、X 射线、超声心动图等],提供(操作成像服务、成像软件、读取分析服务、试验设计和咨询服务等)和最终用户 [合同研究组织 (CRO)、制药和生物技术公司、学术和研究机构等]
No. of Pages: 124 | Report Code: BMIRE00028633 | Category: Life Sciences
No. of Pages: 124 | Report Code: BMIRE00028633 | Category: Life Sciences
临床研究组织 (CRO) 通过使用高质量设施和深厚的主题专业知识提供的服务,协助临床试验的成功实施。 CRO 已开始成为临床试验行业的支柱,其高效且具有成本效益的运营使试验申办者受益。例如,平均而言,CRO 进行和完成临床试验的时间比内部活动少 30%。随着 CRO 数量的增加导致竞争加剧,其中一些企业提供专门的成像服务,从而成为成像 CRO (iCRO)。 iCRO 的一些例子包括 Keosys Medical Imaging 和 Medica Group PLC。 CRO 在成像现场鉴定、标准化图像采集以及读取设计和标准确定等领域提供关键知识见解,从而促进整个北美临床试验成像市场的增长。
北美临床试验成像市场是分为美国、加拿大和墨西哥。美国是临床试验成像最大且增长最快的市场。该地区的市场增长归因于美国逐渐成为领先的临床研究目的地,以及越来越多的公司推出用于临床试验的创新产品。美国已成为领先的临床研究目的地。全球大约一半的临床试验是在美国进行的。此外,大多数制药研究公司更愿意在美国进行临床试验,因为美国拥有完善的医疗基础设施、快速的审批时间表、有利的监管框架以及可接受的临床试验生成的数据。
北美临床试验成像市场按根据模式、产品、最终用户和国家/地区。
根据模式,北美临床试验成像市场分为断层扫描、磁共振成像 (MRI)、超声波、正电子发射断层扫描 (PET)、X 射线、超声心动图等。断层扫描细分市场在 2023 年占据最大的市场份额。
根据产品类别,北美临床试验成像市场分为操作成像服务、成像软件、读取分析服务、试验设计和咨询服务等。运营成像服务领域在 2023 年占据最大的市场份额。
根据最终用户,北美临床试验成像市场分为合同研究组织 (CRO)、制药和生物技术公司、学术和研究机构等。合同研究组织 (CRO) 细分市场在 2023 年占据最大的市场份额。
根据国家/地区,市场分为美国、加拿大和墨西哥。美国在 2023 年占据市场份额。
BioTelemetry Inc、Calyx Inc、eResearch Technology Inc、ICON PLC、IXICO plc、Medical Metrics Inc、Medpace Holdings Inc、VIDA Diagnostics Inc、和 WCG Clinical Inc 是北美临床试验成像市场的领先公司。
Strategic insights for North America Clinical Trial Imaging involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2023 | US$ 704.94 Million |
Market Size by 2028 | US$ 1,025.61 Million |
Global CAGR (2023 - 2028) | 7.8% |
Historical Data | 2021-2022 |
Forecast period | 2024-2028 |
Segments Covered |
By 模式
|
Regions and Countries Covered | 北美
|
Market leaders and key company profiles |
The regional scope of North America Clinical Trial Imaging refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
1. BioTelemetry Inc
2. Calyx Inc
3. eResearch Technology Inc
4. ICON PLC
5. IXICO plc
6. Medical Metrics Inc
7. Medpace Holdings Inc
8. VIDA Diagnostics Inc
9. WCG Clinical Inc
The North America Clinical Trial Imaging Market is valued at US$ 704.94 Million in 2023, it is projected to reach US$ 1,025.61 Million by 2028.
As per our report North America Clinical Trial Imaging Market, the market size is valued at US$ 704.94 Million in 2023, projecting it to reach US$ 1,025.61 Million by 2028. This translates to a CAGR of approximately 7.8% during the forecast period.
The North America Clinical Trial Imaging Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Clinical Trial Imaging Market report:
The North America Clinical Trial Imaging Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Clinical Trial Imaging Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Clinical Trial Imaging Market value chain can benefit from the information contained in a comprehensive market report.